1 / 6

Analysis of Hemoglobinopathies Market applications and company’s active in the industry

Hemoglobinopathies Market size was valued at over USD 4 billion in 2015. High occurrence in underdeveloped nations such as Arab nations, Sub-Saharan region and South East Asia is a major growth driver.<br><br>Get more details @ https://goo.gl/ccaZoW

Toshitbhat
Download Presentation

Analysis of Hemoglobinopathies Market applications and company’s active in the industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hemoglobinopathies Market share research by applications and regions for 2016 – 2023 : Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Regional Analysis of Hemoglobinopathies Market : • In 2015, North America was the largest revenue generating region with around USD 1.2 billion owing to rise in R&D investments, better compensation state, and presence of high quality healthcare infrastructure. Asia Pacific hemoglobinopathies market share is anticipated to increase at 9% CAGR due to rising patient awareness and introduction of manufactured and low cost diagnostic kits. Sickle cell anemia is the most prevalentdisease in West Africa, with nearly 20% of people having sickle cell trait and about 2% of total babies born with a form of the disease. In many regions of Europe, hemoglobin (Hb) disorders are classified as prevalent diseases. • In the U.S., nearly 1,000 babies are born with sickle cell diseases every year. Increasing pervasiveness of several hemoglobinopathy disorders and high level of awareness about related genetic testing has boosted regional growth. The disease does not have a permanent treatment resulting in growing demand for novel products in the pharmaceutical industry.

  3. Application Analysis of Hemoglobinopathies Market : • Most common tools/tests for diagnosis of hemoglobinopathies and thalassemia disorders are pre-implantation genetic diagnosis, genetic and blood testing, alkaline and acid gel electrophoresis, hemoglobin electrophoresis, prenatal genetic testing and HbA2 quantification by ion exchange column chromatography. Increased awareness about genetic testing for diagnosis of sickle cell anemia and other disorders is expected to contribute toward revenue growth in the near future. Genetic testing is an emerging cost-effective approach to reduce the pervasiveness of the disease.

  4. Competitive Market Share of Hemoglobinopathies Market : • Key industry players comprise Alnylam Pharmaceuticals, Gamida Cell, Biogen Idec, AcceleronPharma, SangamoBioSciences, Anthera Pharmaceuticals, Global Blood Therapeutics, Genetix Pharmaceuticals, Mast Therapeutics, Prolong Pharmaceuticals, Emmaus Medical, Calgene Corporation, Invenux, Optinova Ab, and HemaQuest Pharmaceuticals. Companies are aiming on the partnership and licensing deals for sharing the research and development platform. In 2014, SangamoBioSciences and Biogen Idec declared collaboration agreement that targeted hemoglobinopathies market therapeutics development.

  5. Browse Full Market Research Report On Hemoglobinopathies Market @ https://goo.gl/ccaZoW Request for an in-depth table of contents for this report @ https://www.gminsights.com/request-toc/upcoming/470 Gaming Console Market

  6. Stay In Touch Website: www.gminsights.com Social Media:

More Related